As a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Bristol-Myers Squibb supports and complies fully with the EFPIA Disclosure Code for payments made to healthcare professionals (HCPs) and Healthcare Organizations (HCOs). Our collaboration with the healthcare community is an important and necessary aspect of bringing innovative medicines to patients and ensuring understanding of the safe and appropriate use of our medicines for the benefit of patients.
For more information, please visit the Irish Pharmaceutical Health Association website.
Approval number: NOIE2003264
Date: May 2020